Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

482
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
482
Cancer Survival Analysis01:21

Cancer Survival Analysis

402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous sacral neurostimulation of penile erection during radical prostatectomy: surgical technique.

Translational andrology and urology·2026
Same author

Periprocedural anti-thrombotic therapy and priapism recurrence after surgical shunting: a propensity-matched analysis.

The journal of sexual medicine·2026
Same author

Predicting major ischemic priapism: a novel dynamic nomogram based on recurrent ischemic priapism risk factors.

The journal of sexual medicine·2026
Same author

Changes in sexual quality of life in patients with stress urinary incontinence treated with an artificial urinary sphincter; analysis of the artificial urinary sphincter clinical outcomes trial (AUSCO).

The journal of sexual medicine·2026
Same author

Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial.

JAMA internal medicine·2026
Same author

Safety and tolerability of a novel implantable neurostimulator to improve erectile function: a pilot study in patients with spinal cord injury.

The journal of sexual medicine·2026

Related Experiment Video

Updated: Jul 30, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K

Disparities in prostate cancer.

Arthur L Burnett1, Yaw A Nyame2, Edith Mitchell3

  • 1Johns Hopkins Medicine, Baltimore, MD, United States.

Journal of the National Medical Association
|May 18, 2023
PubMed
Summary

Black men face significant racial disparities in prostate cancer, experiencing higher incidence and mortality rates. Addressing complex biological, social, and systemic factors is crucial to reduce these inequities.

Keywords:
Access to treatmentEarly detectionProstate cancerRacial disparitiesSocial determinants of health

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

717
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.9K

Related Experiment Videos

Last Updated: Jul 30, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

717
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.9K

Area of Science:

  • Oncology
  • Public Health
  • Health Disparities Research

Background:

  • Prostate cancer disproportionately affects Black men, being the second leading cause of cancer death in this group.
  • Black men present with higher incidence, mortality, younger age at diagnosis, and increased risk of aggressive prostate cancer compared to White men.
  • Racial disparities persist across the entire prostate cancer care continuum, from screening to treatment.

Purpose of the Study:

  • To review the multifaceted origins of racial disparities in prostate cancer.
  • To propose actionable recommendations aimed at mitigating these inequities and closing the racial gap in prostate cancer outcomes.

Main Methods:

  • Literature review and synthesis of existing research on prostate cancer disparities.
  • Analysis of biological, social, economic, and healthcare system factors contributing to inequities.

Main Results:

  • Racial disparities in prostate cancer are driven by a complex interplay of factors.
  • These factors include biological predispositions, structural inequities (e.g., systemic racism, policy), social determinants of health (e.g., income, education, environment), and healthcare system variables.

Conclusions:

  • Addressing prostate cancer racial disparities requires a comprehensive approach targeting multiple determinants.
  • Actionable recommendations are needed to promote equity in prostate cancer screening, diagnosis, and treatment for Black men.